These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

304 related items for PubMed ID: 23257423

  • 21. Influence of FLT3-internal tandem duplication allele burden and white blood cell count on the outcome in patients with intermediate-risk karyotype acute myeloid leukemia.
    How J, Sykes J, Gupta V, Yee KW, Schimmer AD, Schuh AC, Minden MD, Kamel-Reid S, Brandwein JM.
    Cancer; 2012 Dec 15; 118(24):6110-7. PubMed ID: 22736495
    [Abstract] [Full Text] [Related]

  • 22. [FLT3 mutations in children with acute myeloid leukemia: a single center study].
    Ruan M, Wang YQ, Zhang L, Liu TF, Liu F, Liu XM, Zhang JY, Zou Y, Chen YM, Zhu XF.
    Zhongguo Dang Dai Er Ke Za Zhi; 2011 Nov 15; 13(11):863-6. PubMed ID: 22099191
    [Abstract] [Full Text] [Related]

  • 23. DNMT3A R882 Mutation with FLT3-ITD Positivity Is an Extremely Poor Prognostic Factor in Patients with Normal-Karyotype Acute Myeloid Leukemia after Allogeneic Hematopoietic Cell Transplantation.
    Ahn JS, Kim HJ, Kim YK, Lee SS, Jung SH, Yang DH, Lee JJ, Kim NY, Choi SH, Jung CW, Jang JH, Kim HJ, Moon JH, Sohn SK, Won JH, Kim SH, Kim DD.
    Biol Blood Marrow Transplant; 2016 Jan 15; 22(1):61-70. PubMed ID: 26234722
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Mutant FLT3: a direct target of sorafenib in acute myelogenous leukemia.
    Zhang W, Konopleva M, Shi YX, McQueen T, Harris D, Ling X, Estrov Z, Quintás-Cardama A, Small D, Cortes J, Andreeff M.
    J Natl Cancer Inst; 2008 Feb 06; 100(3):184-98. PubMed ID: 18230792
    [Abstract] [Full Text] [Related]

  • 26. Transplant outcomes of the triple-negative NPM1/FLT3-ITD/CEBPA mutation subgroup are equivalent to those of the favourable ELN risk group, but significantly better than the intermediate-I risk group after allogeneic transplant in normal-karyotype AML.
    Ahn JS, Kim HJ, Kim YK, Jung SH, Yang DH, Lee JJ, Kim NY, Choi SH, Jung CW, Jang JH, Kim HJ, Moon JH, Sohn SK, Won JH, Kim SH, Kim DD.
    Ann Hematol; 2016 Mar 06; 95(4):625-35. PubMed ID: 26692090
    [Abstract] [Full Text] [Related]

  • 27. Patient-specific analysis of FLT3 internal tandem duplications for the prognostication and monitoring of acute myeloid leukemia.
    Schiller J, Praulich I, Krings Rocha C, Kreuzer KA.
    Eur J Haematol; 2012 Jul 06; 89(1):53-62. PubMed ID: 22458420
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. FLT3 and NPM1 mutations in a cohort of AML patients and detection of a novel mutation in tyrosine kinase domain of FLT3 gene from Western India.
    Ghosh K, Swaminathan S, Madkaikar M, Gupta M, Kerketta L, Vundinti B.
    Ann Hematol; 2012 Nov 06; 91(11):1703-12. PubMed ID: 22733614
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [FLT3-ITD detection of free DNA in plasma from 235 patients with acute myeloid leukemia and its clinical significance].
    Zhong L, Meng WT, Zheng Q, Zhou J, Jia YQ.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Oct 06; 17(5):1144-8. PubMed ID: 19840439
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Detection of FLT3 gene mutation in hematologic malignancies and its clinical significance].
    Liu H, Yu H, Jia HY, Zhang W, Guo CJ.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug 06; 15(4):709-13. PubMed ID: 17708788
    [Abstract] [Full Text] [Related]

  • 35. Mutation of FLT3 gene in acute myeloid leukemia with normal cytogenetics and its association with clinical and immunophenotypic features.
    Chauhan PS, Bhushan B, Mishra AK, Singh LC, Saluja S, Verma S, Gupta DK, Mittal V, Chaudhry S, Kapur S.
    Med Oncol; 2011 Jun 06; 28(2):544-51. PubMed ID: 20354824
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Applications of microchip electrophoresis and capillary electrophoresis for screening FLT3-ITD gene mutation in acute myeloid leukemia].
    Leng X, Li LD, Li JL, Huang XJ, Ruan GR.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Feb 06; 22(1):44-9. PubMed ID: 24598649
    [Abstract] [Full Text] [Related]

  • 38. [Analysis of tyrosine kinases gene mutations in core binding factor related acute myeloid leukemia and its clinical significance].
    Qiao M, Li WY, Sun AN, Chen SN, Liang JY, Ding ZX, Feng YF, Wu DP.
    Zhonghua Xue Ye Xue Za Zhi; 2011 Oct 06; 32(10):679-83. PubMed ID: 22339826
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.